Importantly, this stimulated HCC cell migration was not inhibited by celastrol, indicating that ROCK2-ezrin signaling drives HCC cell migration and inhibition of ROCK2 is sufficient to attenuate the migration (Fig. 5B). The gene discussed is ROCK2; the disease is hepatocellular carcinoma.